6323 completed, 1066 unknown, 751 recruiting, 523 terminated. 2345 Not applicable, 1777 Phase 2, 1470 Phase 3, 953 Phase 1, 893 Phase 4.
Follow Hypersensitivity: new trials by email Literature Review of Hypersensitivity trials Research Report on Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients Skin Cleanser Combination No.1 - Atopic Dermatitis | Phase 4 | Not yet recruiting | Boston Children's Hospital | 100 | 2031-01-01 | 2026-03-10 |
| Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis Ivermectin Pill - Atopic Dermatitis | Phase 2 | Withdrawn | Stanford University | 2030-12-01 | 2024-12-02 | |
| Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis Site specific standard of care comparison - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis | Withdrawn | Massachusetts General Hospital | 2030-01-01 | 2026-01-16 | ||
| EFFECT OF AYURVEDA TREATMENT IN ALLERGIC RHINITIS AYURVEDA treatment protocol, Control(Citrizine 10mg) - Allergic Rhinitis (AR) | Not applicable | Not yet recruiting | Amrita Vishwa Vidyapeetham | 104 | 2028-06-30 | 2026-06-04 |
| Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis EC-18, Placebo EC-18 - Atopic Dermatitis | Phase 2 | Not yet recruiting | Enzychem Lifesciences Corporation | 150 | 2027-05-01 | 2026-08-28 |
| Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age Abrocitinib, Placebo - Atopic Dermatitis | Phase 3 | Not yet recruiting | Pfizer | 90 | 2027-05-01 | 2026-09-16 |
| Rapid Escalation Oral Immunotherapy to Achieve Remission in Children With Cashew Allergy cashew oral immunotherapy - Food Allergy in Children | Not applicable | Not yet recruiting | Murdoch Childrens Research Institute | 25 | 2027-05-01 | 2026-11-03 |
| Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia) linvemastat, Placebo - Asthma (Diagnosis), Pulmonary Function | Phase 2 | Not yet recruiting | Foresee Pharmaceuticals Co., Ltd. | 135 | 2027-03-01 | 2026-07-20 |
| UNC Cashew Sublingual Immunotherapy Cashew sublingual immunotherapy, Placebo sublingual immunotherapy - Cashew Nut Allergy, Tree Nut Allergies | Phase 2 | Not yet recruiting | University of North Carolina, Chapel Hill | 45 | 2027-03-01 | 2026-10-20 |
| Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy HDM sublingual Immunotherapy, Placebo - Asthma, Allergy | Phase 2 | Withdrawn | Boston Children's Hospital | 2027-02-01 | 2024-11-26 | |
| Prevent Wheeze Trial Dexamethasone 0.6 mg/kilogram body weight single dose, Placebo - Lower Respiratory Tract Infection (LRTI), Recurrent Wheezing | Phase 4 | Not yet recruiting | Norwegian University of Science and Technology | 486 | 2027-02-01 | 2026-10-05 |
| Changes in Symptom and Quality of Life in Patients With Uncontrolled Asthma Treated With Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Budesonide/Glycopyrronium/Formoterol fumarate metered dose inhaler - Asthma, Uncontrolled Asthma | Not yet recruiting | AstraZeneca | 200 | 2027-01-29 | 2026-11-12 | |
| Interest of a Targeted Therapy for the Treatment of a Severe Form of Hypersensitivity to Drug (DRESS Syndrome) Benralizumab 30 MG/ML [Fasenra], Placebo Comparator: Placebo-Control Arm 0.9% Sodium Chloride - DRESS Syndrome | Phase 2 | Not yet recruiting | University Hospital, Lille | 96 | 2027-01-06 | 2026-05-15 |
| Educational Needs of Patients With Severe Asthma on Targeted Immunotherapies Initial assesment interwiew, Intake Interview with the Patient - Severe Asthma | Not yet recruiting | University Hospital, Angers | 20 | 2027-01-04 | 2026-10-02 | |
| GOAt Milk Formula-based Ladder Versus Cow's Milk Ladder oral food challenge (OFC) - Food Allergy, Cow's Milk Protein Allergy | Not applicable | Not yet recruiting | Medical University of Warsaw | 92 | 2027-01-02 | 2026-08-31 |
| Educational Eczema Video Intervention in-clinic video intervention, at home video intervention - Eczema | Not applicable | Withdrawn | Boston Children's Hospital | 2027-01-01 | 2026-10-19 | |
| Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy Partially Hydrolyzed Whey Protein Formula, Intact Cow's Milk Protein Formula - Mild Allergic Symptoms in Infants, Infant Feeding Intolerance | Not applicable | Not yet recruiting | Ruijin Hospital | 160 | 2027-01-01 | 2026-08-18 |
| Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) Slow Release DHEA, Placebo - Asthma | Phase 2 | Not yet recruiting | Indiana University | 30 | 2027-01-01 | 2026-02-27 |
| Nebulized Ketamine for Severe Asthma Attacks in Children Ketamine (1 mg/kg), Placebo - Asthma Acute, Exacerbation of Allergic Asthma | Phase 2 | Not yet recruiting | Sultan Qaboos University | 60 | 2027-01-01 | 2026-07-27 |
| Immunotherapy for Curing Toddlers With Severe Food Allergy - a Paradigm Shift From Passive to Active Treatment With Multi-allergen Oral Immunotherapy OIT multiallergen powder, Placebo powder - Food Allergy in Children | Not applicable | Not yet recruiting | Odense University Hospital | 80 | 2027-01-01 | 2026-10-27 |
Showing 20 of 9615. Sign in to see all of them.
Asthma (4474) · Dermatitis, Atopic (1522) · Rhinitis, Allergic (682) · Pulmonary Disease, Chronic Obstructive (456) · Rhinitis, Allergic, Seasonal (384) · Eczema (370) · Food Hypersensitivity (360) · Sarcoidosis (249) · Eosinophilic Esophagitis (234) · Conjunctivitis, Allergic (197) · Chronic Urticaria (194) · Rhinitis, Allergic, Perennial (178) · Angioedemas, Hereditary (169) · Peanut Hypersensitivity (165)
Immune System Diseases (9550) · Hypersensitivity, Immediate (8497) · Respiratory Tract Diseases (5783) · Respiratory Hypersensitivity (5568) · Lung Diseases (4577) · Bronchial Diseases (4542) · Lung Diseases, Obstructive (4466) · Skin and Connective Tissue Diseases (2299) · Skin Diseases (2206) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1874) · Genetic Diseases, Inborn (1822) · Pathological Conditions, Signs and Symptoms (1652) · Skin Diseases, Eczematous (1601) · Dermatitis (1571)
Fluticasone (244) · Budesonide (203) · montelukast (179) · Albuterol (162) · Omalizumab (159) · dupilumab (159) · Mometasone Furoate (107) · Formoterol Fumarate (105) · Beclomethasone (88) · Fluticasone-Salmeterol Drug Combination (87) · Salmeterol Xinafoate (81) · Blood Specimen Collection (80) · Budesonide, Formoterol Fumarate Drug Combination (80) · Sodium Chloride (66) · benralizumab (58)
AstraZeneca (347) · GlaxoSmithKline (346) · Novartis Pharmaceuticals (157) · Organon and Co (152) · National Institute of Allergy and Infectious Diseases (NIAID) (115) · Sanofi (99) · Pfizer (89) · National Heart, Lung, and Blood Institute (NHLBI) (82) · Assistance Publique - Hôpitaux de Paris (77) · Boehringer Ingelheim (71) · Chiesi Farmaceutici S.p.A. (62) · Johns Hopkins University (60) · Imperial College London (58) · Regeneron Pharmaceuticals (58) · University of North Carolina, Chapel Hill (56)
United States (3407) · Germany (942) · Canada (921) · United Kingdom (891) · France (720) · China (609) · Poland (542) · Spain (533) · Italy (467) · Netherlands (360) · Japan (339) · Australia (338) · South Korea (287) · Belgium (275) · Hungary (269)
PMID 36472162, PMID 36326435, PMID 27881132, PMID 35636689, PMID 39393433, PMID 39588375, PMID 31319851, PMID 33006765, PMID 33305842, PMID 33826132, PMID 34389504, PMID 29400693, PMID 32926419, PMID 35691614, PMID 42162528, PMID 33217063, PMID 34406619, PMID 36255569, PMID 36723913, PMID 38127464, PMID 38814736, PMID 38896380, PMID 40993471, PMID 19001265, PMID 26704701, PMID 30954640, PMID 33165005, PMID 34037993, PMID 36408587, PMID 36853224, PMID 39104653, PMID 40028832, PMID 18331513, PMID 20818886, PMID 22329608, PMID 23312695, PMID 23878046, PMID 24184147, PMID 24712435, PMID 28065396, PMID 29174062, PMID 29536781, PMID 29656145, PMID 31066001, PMID 32180164, PMID 33453450, PMID 34098955, PMID 34142350, PMID 35061234, PMID 35342978
2018 (64), 2023 (53), 2015 (43), 2019 (43), 2017 (42), 2014 (41), 2016 (41), 2025 (34), 2009 (33), 2008 (18), 2004 (9), U10HL098115 (8), U10HL074212 (6), 2005 (5), P01HL107202 (5)